SightfileU.S. market data from official filings

SPECTRAL AI INC (MDAI)

Name: SPECTRAL AI INC (MDAI) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001833498 · EDGAR filings · Updated 2026-07-08

SPECTRAL AI INC (MDAI) has reported institutional ownership of 10.4%, with 23 institutional managers holding positions valued at $4.87M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

10.4%

Institutional managers

Reported 13F value

$4.87M

Insider activity

6 trans.

$0 net flat

Data flags

3 active

from SEC filings

Latest updates

2026-07-08 — Current report (8-K) filed
2026-06-29 — Insider transaction reported (Form 4)
2026-06-01 — Current report (8-K) filed
2026-06-01 — Insider transaction reported (Form 4)
2026-05-27 — Insider transaction reported (Form 4)
2026-05-26 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SPECTRAL AI INC has 23 institutional holders and institutional ownership of 10.4%.

Insider activity

Insiders reported 6 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-12-11 (recurring since 2021-06-04) — source filing. The authoritative details are those stated in the filing itself.

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2023-08-14 (recurring since 2022-03-31) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2021-11-22 (recurring since 2021-11-22) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Marker Therapeutics Inc (MRKR) · CUE BIOPHARMA (CUE) · ELECTROCORE INC (ECOR) · NASUS PHARMA LTD (NSRX) · XBiotech Inc (XBIT) · HYPERION DEFI INC (HYPD)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.